The misfolding of nascent proteins, or the unfolding of proteins after synthesis is complete, can occur in response to numerous environmental stresses, or as a result of mutations that de-stabilize protein structure. Cells have developed elaborate protein quality control systems that recognize improperly folded proteins and either refold them or facilitate their degradation. One such quality control system is the unfolded protein response, or the UPR. The UPR is a highly conserved signal transduction system that is activated when cells are subjected to conditions that alter the endoplasmic reticulum (ER) in ways that impair the folding of nascent proteins in this organelle. Recent observations indicate that in the heart, the UPR is activated during acute stresses, including ischemia/reperfusion, as well as upon longer term stresses that lead to cardiac hypertrophy and heart failure. Moreover, certain aspects of the UPR are activated during, and are required for proper heart development. This review summarizes recent studies of the UPR in the heart, focusing on the possible roles of the UPR in contributing to, or protecting from ischemia/reperfusion damage.
Introduction
The function of most proteins depends on their three-dimensional conformation, which requires correct folding. The bulk of cellular protein synthesis takes place on cytosolic free ribosomes. However, depending on the cell type, up to 35% of protein synthesis is in the rough endoplasmic reticulum (ER), which is where all secreted proteins, as well as proteins that are targeted to membranes and organelles, are synthesized [1] . Under optimal conditions, numerous chaperones and other proteins and factors ensure efficient nascent protein folding; however, perturbation of folding machinery components decreases protein folding efficiency. Initially, the accumulation of misfolded proteins triggers biochemical events designed to augment protein folding capacity. However, the continued accumulation of terminally misfolded proteins leads to their degradation by a wellstudied protein quality control system, involving recognition, ubiquitination and degradation by proteasomes and, eventually, to cell death. Protein quality control systems are located in several cell compartments including the cytosol and the ER; several reviews of the cytosolic protein quality control system in the heart have recently appeared [2, 3] . Accordingly, this review focuses on ER-associated protein quality control system, also known as the unfolded protein response (UPR).
The unfolded protein response
The unfolded protein response (UPR) is a conserved signal transduction system that is activated by stresses that impact the efficiency of protein folding in the rough ER [4] [5] [6] [7] . Optimal protein folding in the ER depends on maintaining the proper balance of numerous components in the ER that contribute to folding of proteins during synthesis. For example, the correct ER redox status is required for protein disulfide bond formation, which is an oxygen-requiring process. Also, maintenance of suitable levels of protein glycosylation substrates, as well as sufficient glycosylation enzymatic machinery, is required, since most proteins made in the ER are glycosylated. Finally, ER calcium and ER-resident chaperones must be present at the levels that facilitate optimal folding of nascent ER proteins.
Experimentally, the ER environment can be perturbed by substances, such as dithiothrietol, thapsigargin, or tunicamycin, which alter redox status, calcium levels and protein glycosylation in the ER, respectively [4, [8] [9] [10] . When cells are treated with one of these compounds, or if they are starved of glucose and oxygen, the latter of which mimics ischemia, ER protein folding is impaired, and the accumulation of mis-folded, dysfunctional proteins signals the initiation of ER stress [11] .
ER stress is initially sensed by the 3 ER transmembrane proteins, protein kinase R-like ER kinase (PERK) [12] , activating transcription factor-6 (ATF6) [13, 14] and inositolrequiring enzyme-1 (IRE-1) [15, 16] , which serve as the primary proximal effectors of the UPR. Numerous studies in yeast, as well as mammalian cell lines and a few tissues, have contributed considerably to our understanding of the mechanisms of action of each of these effectors. Several excellent reviews report on the results of these studies [17] ; accordingly, the following is a summary of the mechanisms by which these effectors sense ER stress and mediate downstream signals.
When ER protein folding is functioning efficiently, the ER luminal domains of PERK, ATF6 and IRE-1 are bound to the abundant ER-resident chaperone, glucose-regulated protein 78 (GRP78). Under these conditions, these proximal effectors of the UPR are inactive (Fig. 1A) . However, when ER protein folding is disrupted, and misfolded proteins begin to accumulate, GRP78 translocates from PERK, IRE-1 and ATF6 to the misfolded proteins in an apparent effort to aid in folding [18] [19] [20] [21] [22] . This translocation of GRP78 leads to the activation of all 3 proximal effectors of the UPR (Fig. 1B) and is considered one of the earliest signs of ER stress. Once activated, the 3 proximal Fig. 1 . The unfolded protein response: (A) Under non-stressed conditions, proteins that are synthesized in the rough ER are efficiently folded. The ER-resident molecular chaperone, glucose-regulated protein-78 (GRP78), is associated with the luminal domains of the 3 proximal effectors of the unfolded protein response (UPR), PKR-like ER kinase (PERK), inositol-required enzyme-1 (IRE-1) and activating transcription factor-6 (ATF6). Under these conditions, these 3 UPR effectors are inactive in terms of activating downstream effects of the UPR. (B) Stresses that perturb the redox status of the ER lumen, alter ER calcium levels, or disrupt the ER protein glycosylation machinery, result in the accumulation of mis-folded, dysfunctional proteins in the ER lumen, which initiates ER stress. Upon ER stress, GRP78 translocates from the luminal domains of PERK, ATF6 and IRE-1 to the misfolded proteins in the ER lumen in an effort to assist in folding. Under these conditions, PERK, ATF6 and IRE-1 and ATF6 are activated. (C) The PERK, ATF6 and IRE-1 branches of the UPR each mediate the transcriptional induction of ER stress response genes via the transcription factors, ATF4, ATF6 and XBP1, respectively. In addition, PERK can mediate global translational arrest by phosphorylation eIf2α, and IRE-1 can mediate the activation of JNK and caspase-12. Translational arrest decreases the workload on the ER, allowing time for recovery; however, the mRNAs encoded by many ER stress response genes have evolved structural features that allow them to escape this translational arrest, which is important for the upregulation of ER stress response proteins upon acute stress. The JNK and caspase-12 branches of the UPR contribute to programmed cell death that takes place upon chronic ER stress. Many ER stress response genes encode ERtargeted chaperones, and other ER proteins that are designed to stabilize and/or reestablish an ER luminal environment that is suitable for nascent ER protein folding, facilitating cell survival and recovery from acute ER stress (Survival/Recovery). However, if the stress is not resolved, ER stress response genes induced upon chronic stress lead to apoptotic cell death (Apoptosis).
effectors of the UPR mediate the downstream, or distal effects of ER stress.
Proximal effectors of ER stress (PERK, IRE-1 and ATF6)

PERK
PERK is a transmembrane ER protein; upon ER stress, and the relocation of GRP78 from the luminal domain of PERK to misfolded proteins, and the subsequent homodimerization of PERK, lead to trans-autophosphorylation, much like activated growth factor receptors. This autophosphorylation activates PERK, further, which phosphorylates the ribosomal protein, eIF2α. Phosphorylation of eIF2α decreases its efficiency as an initiator of translation, which leads to decreased translation of most cellular mRNAs ( Fig. 1C ; translation arrest) [18] . This translational arrest, which is transient, reduces the protein synthesis load in the ER, facilitating recovery of ER homeostasis and the re-establishment of efficient ER protein folding [23] . Although most mRNAs are inefficiently translated upon PERK activation, paradoxically, the mRNA that encodes activator of transcription factor-4 (ATF4) is translated more efficiently when eIF2α is phosphorylated. This leads to increased levels of ATF4, which serves important roles as a transcriptional inducer of a certain ER stress response genes, such as those that encode amino acid transporters, which assist in the recovery from the stress ( Fig. 1C ; ATF4).
IRE-1
Much like PERK, IRE-1 is an ER transmembrane protein, which, upon ER stress, forms homodimers which facilitate transautophosphorylation. However, in contrast to PERK, upon ER stress, IRE-1 exhibits a novel endoribonuclease activity, which splices the mRNA that encodes active x-box binding protein-1 (XBP1). This unusual splicing event, which takes place in the cytosol, generates a transcript with a new open reading frame that encodes the expression of an active form of XBP1, a basic leucine-zipper (bZip) transcription factor that induces numerous ER stress response genes ( Fig. 1C ; IRE1 XBP1) [21, 24] .
ATF6
Like PERK and IRE-1, ATF6 is an ER transmembrane protein that also exists as a dimer in association with GRP78 under non-stressed conditions. In further comparison, upon ER stress GRP78 dissociates from the ER luminal domain of ATF6. However, in contrast to the other two effectors, which remain associated with the ER, ATF6 relocates to the Golgi, where two proteases, site-1 and site-2 proteases, cleave it in, or near the transmembrane region. After these cleavage events, the cytosolic region of ATF6, which has several putative nuclear localization signals, translocates to the nucleus where it can form homodimers or heterodimers with a small group of bZip transcription factors, which includes XBP1, leading to the transcriptional regulation of ER stress response genes ( Fig. 1C; ATF6) [25, 26] . A second isoform of ATF6, ATF6β [27] , as well as other ATF6-related proteins, such as Oasis [28] , Luman [29, 30] , CREB4 [31] , CREB-H [31] and BBF2H7 [32] , have since been discovered. Like ATF6, all of these isoforms are ER transmembrane proteins that are cleaved and translocate to the nucleus upon ER stress. Moreover, in theory, each has the ability to dimerize with other members of this bZip transcription factor family. Although the exact roles of these ATF6 isoforms are not completely known, it appears as though ATF6β has less ability to induce ER stress response genes than ATF6 [33] and may even serve as an inhibitor of ATF6 [34, 35] . Additionally, some of the other isoforms exhibit tissue-restricted expression patterns, implying that they may contribute to mediating ER stress in a cell-type-specific manner.
Distal effectors of the UPR
Many of the XBP1 and ATF6 inducible genes that have been characterized to date can be induced by either transcription factor. Thus, there is a great deal of redundancy between these two UPR pathways, although the reasons for this redundancy are not yet clear. However, the recent development of ATF6 knock out mice has clarified the existence of numerous ER stress response genes that are dependent upon ATF6 for maximal induction during ER stress [33] . Most of the genes induced by XBP1 and/or ATF6 encode mRNAs with structural features allowing them to escape PERK-mediated translational arrest. Genes induced upon acute ER stress encode proteins that improve the folding of nascent proteins in the ER lumen and facilitate the degradation of dysfunctional misfolded proteins. The degradation of terminally misfolded ER proteins is performed by ER-associated protein degradation or ERAD. ERAD is a complex process involving the recognition of misfolded ER proteins, followed by the retrotranslocation of these proteins across the ER membrane to the cytosolic face of the ER. Protein degradation machinery, located on the cytosolic face of the ER, is dedicated to the ubiquitination and proteasomemediated degradation of terminally misfolded ER proteins [36] [37] [38] . Together, the ER luminal and ERAD-associated proteins function to resolve the ER stress, fostering the recovery of efficient ER protein folding and cell survival ( Fig. 1D ; Survival/ Recovery).
If the UPR signals activated in the early phases of ER stress are not sufficient to resolve the stress, continued activation of the proximal effectors leads to the upregulation of a different collection of UPR-inducible proteins ( Fig. 1D; Apoptosis) , as well as the activation of other signaling pathways, that combine to promote cell death ( Fig. 1C ; JNK and caspase-12) [39, 40] . ER stress can also promote cell death in collaboration with the mitochondrial apoptosis pathway. For example, ER stress causes the release of cytochrome c [41] . Moreover, the proapoptotic Bcl-2 family members, Bax and Bak, associate with the ER, where they activate IRE1, thus linking mitochondrial and ER-mediated apoptotic pathways [42] . Accordingly, the strength and duration of the ER stress contribute to determining the ultimate role of the UPR as either a survival or a deathoriented signaling pathway.
One of the most studied ER stress response genes is GRP78, which is also expressed in many cell types under non-stressed conditions, but upon activation of the UPR, is induced further. The GRP78 promoter has ER stress response elements (ERSEs) that bind XBP1 or ATF6, which is required for transcriptional induction during ER stress [14, 43, 44] . Like GRP78, most of the other ER stress response genes that have been characterized also have ERSEs [45] , indicating that this transcriptional induction mechanism is highly conserved among genes that are induced during the UPR. Increased expression of GRP78 during the UPR enhances the protein folding capacity in the ER; if the load of misfolded proteins is reduced via this mechanism, by binding to the proximal effectors of ER stress, GRP78 contributes to inactivating the UPR, signaling resolution of the stress. Moreover, it was shown that during long-term ER stress, GRP78 redistributes from the ER to other locations, including the cytosol, where it can bind to and prevent the release of caspase-12 from the ER, thus inhibiting the apoptotic phase of the UPR [46] .
Ischemia as an activator of the UPR
Although studies employing chemicals to induce ER stress in cultured cells and, in a few cases, in vivo, have been useful in delineating the molecular details of the UPR, such conditions are relatively extreme and are not likely to represent physiologically meaningful stresses. In contrast, the lack of oxygen and nutrients that take place during ischemia are known to affect the ER environment in ways predicted to activate the UPR. For example, glucose deprivation was one of the first maneuvers shown to activate the UPR, probably by impeding protein glycosylation in the ER, thus mimicking the effects of tunicamcyin [9, 10] . GRP78 was named a glucose-response protein based on its induction in cultured cells subjected to glucose starvation [47, 48] . Additionally, the machinery responsible for disulfide bond formation in the ER requires molecular oxygen for proper function [49] .
Some of the earliest studies on the effects of ischemia/reperfusion on the UPR were carried out in the brain. For example, it was shown that in ischemic rabbit brain, several features of the UPR were activated, including PERK, eIF2α phosphorylation, translational arrest and XBP1 mRNA splicing [50] . Moreover, ischemic pre-conditioning in the brain has been shown to induce GRP78 and to protect from further ischemic damage [51] . Gene array studies have shown that transient cerebral artery occlusion increases the expression of numerous UPR-dependent genes in the brain [52] . In addition to brain, numerous studies of the UPR have been carried out in tumors and cancer cell lines. For example, the UPR was shown to be activated in ischemic regions of tumors and in cultured tumor cells subjected to hypoxia; in both contexts, UPR activation was protective [53] . As a result of numerous studies in the tumor cell context, it has been suggested that the UPR provides a selective advantage to some aggressively growing solid tumors, where the rate of growth sometimes surpasses neo-angiogenesis, leading to ischemia and activation of the UPR [54] . In this context, since the UPR protects the growing tumor, and has been shown to contribute to malignant progression, the therapeutic strategy has been to inhibit the UPR in order to moderate tumor growth [55] .
The demonstration that the UPR is activated in hypoxic tumor cells and tissue, as well as is the ischemic brain, prompted studies of whether the UPR is activated by ischemic in the heart, or by simulated ischemia in cultured cardiac myocytes. GRP78 was shown to increase in mouse hearts subjected to ex vivo ischemia/reperfusion, as well as in surviving cardiac myocytes that border the infarct zone in a mouse model of in vivo myocardial infarction [56] . Another study showed that GRP78 was induced and XBP1 was activated in hearts subjected to ischemia/reperfusion in vivo [57] . Transgenic overexpression of monocyte chemoattractant protein-1 (MCP-1) in mouse hearts was shown to induce ischemic heart disease and increase the expression of numerous ER stress response genes, including GRP78 [58] . Also, a number of ER stress response genes, including protein disulfide isomerase, were shown to be induced in the peri-infarct zone in a mouse model of myocardial infarction [59] . Several studies have shown that simulating ischemia or ischemia/reperfusion in cultured neonatal rat or adult mouse ventricular myocytes, or in the HL-1 atrial myocyte cell line, activates XBP1 and increases the expression of GRP78, and other genetic markers of the UPR [56, 57, [59] [60] [61] .
Thus, ischemia and ischemia/reperfusion activate numerous features of the UPR in cardiac myocytes in vivo and in vitro; however, in contrast to studies in tumor cells and in the brain, where ER stress has been shown to be protective, it is less clear what function the UPR serves in the cardiac context. Some studies support protective roles for the UPR; for example, preactivation of ATF6 in the hearts of transgenic mice was shown to protect the heart from ischemia/reperfusion damage [62] , suggesting that under these conditions, genes induced by the ATF6 branch of the UPR served protective functions. Also, adenoviral-mediated overexpression of the ER stress response gene for protein disulfide isomerase decreased the size of infarcts in mouse hearts subjected to in vivo coronary artery ligation [59] . In other studies, it was shown that upregulation of GRP78 during ischemic pre-conditioning is responsible for protecting cultured cardiac myocytes from further ischemic injury [63] , and that preinducing ER stress response genes with tunicamycin protects H9c2 cardiomyocytes from death induced by simulated ischemia/reperfusion [64] . It has also been shown that overexpression of the ER stress response gene, GRP94, protects cultured cardiac myocytes from death in response to simulated ischemia [65] . Taken together, these studies suggest that when the UPR is activated in the heart during ischemia, or ischemia/reperfusion, it may contribute to a protective stress response mounted by cardiac myocytes.
In contrast to the studies cited above, other results support the possibility that the UPR may contribute to ischemia/reperfusion damage in the heart. In cultured cardiac myocytes, it was shown that AMP kinase and ER stress were both activated during simulated ischemia, and that in this context, by inhibiting ER stress, AMP kinase protected the cells from hypoxic injury [60] . ER stress has been shown to activate autophagy-mediated cell death cardiac myocytes subjected to simulated ischemia/ reperfusion [66] . Additionally, in cultured cardiac myocytes, ER stress leads to the activation of PKC delta, but that inhibiting delta PKC activation decreases ER stress-mediated apoptosis [57] . Overexpression of the ER stress response gene, p53-upregulated modulator of apoptosis (PUMA), increased apoptosis in cultured cardiomyocytes subjected to activation of the UPR [67] , and targeted deletion of PUMA in mouse hearts was associated with reduced cardiomyocyte death upon ex vivo ischemia/reperfusion [68] .
Although the reasons underlying the seemingly paradoxical results described above are not known, it is possible that like some other signaling pathways, the UPR can mediate both protective and damaging effects in the heart, depending upon the context. In support of this possibility is a study which showed that in cultured cardiac myocytes, simulated ischemia activated protective aspects of the UPR at early times, but at later times, apoptotic features of the UPR were dominant [61] . This finding is consistent with general views that during the initial phases of ER stress, the UPR mediates induction and activation of protective genes and proteins, but upon continued ER stress, pro-apoptotic machinery is activated. Although the mechanistic details of such a dual function for the UPR are still being worked out, one possibility is that ATF6, PERK and IRE-1 may be activated to different extents, depending upon the strength and nature of the ER stress, and that some effectors, e.g., ATF6, might mediate activation of mostly protective genes [33, 62] , while others, e.g., PERK, may induce a greater number of pro-apoptotic genes. In a study designed to examine this possibility, it was shown that in cultured fibroblasts, even mild ER stress activates the 3 proximal effectors of the UPR to similar extents, which argues against selective activation of ER stress response effectors as a mechanism [69] . In the same study, it was shown that during mild ER stress, survival is favored due to the intrinsic instabilities of mRNAs and proteins that promote apoptosis compared to those that facilitate protein folding and adaptation. Thus, it is possible that in the heart, brief ischemic stress leads to a change in the UPR-regulated proteome that fosters protection, while more prolonged ischemia alters the proteome in ways that contribute to damage.
Future directions
This review has focused on roles for the UPR in the ischemic myocardium, which are just beginning to be appreciated. In this context, many potentially important studies concerning the function of the UPR in the heart are yet to be carried out. For example, it will be important to determine what parameters dictate when the UPR fosters protection and when in contributes to damage in the ischemic heart. This information, coupled with a more complete understanding of the levels and functions of genes, and ultimately, UPR-regulated proteins, during ischemic stress, will be required in order to fully appreciate the impact of ER stress on myocardial function in the ischemic heart. It will also be important to determine how the UPR interacts with and is influenced by the numerous other signaling pathways known to be activated in the ischemic heart, including hypoxia-inducible factor-1, AMP kinase, nitric oxide synthase, nuclear factor kappa B, as well as the mitogen-activated protein kinase and protein kinase C families. Finally, there is evidence that in addition to ischemia, the UPR is activated in the heart under other conditions, including hypertrophy and heart failure [58, 70, 71] . Moreover, the UPR appears to be important for cardiac development [72, 73] , as shown by the finding that the targeted deletion of the XBP1 in mice leads to embryonic lethality due to incomplete heart development [74] . Thus, it is apparent that the ER-associated UPR protein quality control system plays important roles in the normal heart, as well as the stressed and diseased heart, underscoring the importance of future studies aimed at elucidating the roles of this intricate signaling pathway in the heart.
